Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Synthetic peptide gamma-D-Glutaminyl-L-Tryptophan has antituberculosis activity in murine model Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
Dose-dependent inhibitory effect of Roflumilast, a new, orally active, selective phosphodiesterase 4 inhibitor, on allergen-induced early and late asthmatic reaction Source: Eur Respir J 2002; 20: Suppl. 38, 110s Year: 2002
Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs Source: International Congress 2017 – Novel studies on bronchodilators and cough Year: 2017
Highly lipophilic fatty acid esters of the active metabolite of ciclesonide formed in vitro in rat lung tissue Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004
A novel anti-inflammatory role for thymosin beta 4 sulfoxide in a murine model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Lung reactivity to a new hybrid piridin-phenothiazinic derivative in rats Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Low concentration of phenol in medical solutions can induce bronchoconstriction and toxicity in murine, rat and human lungs. Source: International Congress 2018 – Basic pharmacology Year: 2018
A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Roflumilast N-oxide reduces human fibroblast function Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
The dissociated steroid receptor ligand from plant origin called compound A (CpdA) inhibits the production of steroid-resistant chemokines induced by TNFα/IFNγ in airway smooth muscle (ASM) cells in both asthma and healthy subjects Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
A molecule derived from mycobacterium tuberculosis Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in miceSource: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019
In vitro pharmacological characterization of CHF6001, a novel selective phosphodiesterase 4 (PDE4) inhibitor with a robust anti-inflammatory profile Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014
In vitro pharmacological characterization of a novel p38α (MAPK14) inhibitor designed for inhaled delivery Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
The formation and effects of extracellular DNA traps in a murine asthma model Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Efficacy of a novel PI3Kd inhibitor, DS-1515 in animal models of asthma Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018